Bright Green Corporation is investing in drug production with bankruptcy reorganization plan.

From GlobeNewswire: 2025-01-27 20:17:00

Bright Green Corporation plans to invest $3.5 billion in new mega farm owner/operators to strengthen the Drugs Made in America supply chain with federal loan guarantees. The company entered into a Restructuring Support Agreement with major shareholder Lynn Stockwell to file for Chapter 11 bankruptcy reorganization. The new CEO, Lynn Stockwell, aims to bring drug production back to the U.S. and create new jobs. The proposed Plan includes funding an Exit Facility, paying off claims, and issuing new common stock. The company expects to file for Chapter 11 bankruptcy in the Southern District of Florida and change its name to Drugs Made in America Corp upon emergence.



Read more at GlobeNewswire: Bright Green Corporation Has Signed Agreement with Majority